NIH Funding Opportunities (Notices, PA, RFA)

Subscribe to NIH Funding Opportunities (Notices, PA, RFA) feed
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 16 min 37 sec ago

Collaborative Human Tissue Network (CHTN) (UM1 Clinical Trials Not Allowed)

Fri, 2018-06-22 12:55
Funding Opportunity RFA-CA-18-025 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), is to support the Cooperative Human Tissue Network (CHTN). The goal for CHTN is to collect and distribute high quality human tissue specimens to facilitate basic and early translational cancer research, as well as assay development. The CHTN is designed as a unique biospecimen resource in that it is based on prospective collection and distribution of samples upon specific investigators requests. Samples to be collected from patients include pre-cancerous, cancerous, and benign neoplastic tissues, as well as specimens corresponding to non-neoplastic diseases and uninvolved tissues. This FOA solicits applications for CHTN awards from institutions/teams capable of contributing to the mission of CHTN by: (1) providing prospective investigator-defined procurement of high-quality malignant, benign, diseased, and uninvolved (normal adjacent) tissues and fluids from patients throughout North America and elsewhere; (2) assisting individual investigators with regard to specific specimen needs of their research; (3) assisting in developing and disseminating knowledge on high quality practices for successfully operating a biospecimen repository; and (4) educating the community about the importance of the availability of high quality human tissue specimens for medical research. Depending on their profile and capabilities, applicants must indicate whether they propose to function as the CHTN adult biospecimen division or the pediatric specimen division. Nonetheless, it will be acceptable for an adult biospecimen division, if capable, to contribute pediatric samples for networked requests. This FOA is open to all qualified applicants irrespective of their previous association with the CHTN.

Clarification: Assignment Deadlines for Applications Submitted Under the NIH Continuous Submission Policy

Fri, 2018-06-22 11:53
Notice NOT-OD-18-178 from the NIH Guide for Grants and Contracts

High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Not Allowed)

Thu, 2018-06-21 10:18
Funding Opportunity RFA-AG-19-015 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to provide infrastructure support for advancing development of specific high priority areas of behavioral and social research of relevance to aging. The infrastructure support will facilitate research networks through meetings, conferences, small scale pilots, short term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and build resources for advancing aging-relevant research in the field at large. Network applications are limited to the following areas: (1) Midlife Reversibility of Biobehavioral Risk associated with Early Life Adversity, (2) Stress Measurement, (3) Reproducibility in the Social and Behavioral Sciences, (4) Life Course Health Disparities at Older Ages, (5) Genomics of Behavioral and Social Science (6) Integrating Animal Models to Inform Behavioral and Social Research on Aging, and (7) Rural Aging.

High-Priority Behavioral and Social Research Networks in Alzheimer's Disease and Alzheimer's Disease Related Dementias (R24 Clinical Trial Not Allowed)

Thu, 2018-06-21 10:18
Funding Opportunity RFA-AG-19-016 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to provide infrastructure support to provide infrastructure support for advancing development of specific high priority areas of behavioral and social research of relevance to Alzheimers disease and Alzheimers disease related dementias (AD/ADRD). The infrastructure support will facilitate research networks through meetings, conferences, small scale pilots, short term educational opportunities (such as intensive workshops, summer institutes, or visiting scholar programs), and dissemination to encourage growth and development of specified priority areas and build resources for advancing aging-relevant research in the field at large. Network applications are limited to the following areas: (1) AD/ADRD care and services research and (2) the coordination of international studies conducting the Harmonized Cognitive Assessment Protocol.

Request for Information (RFI): Evaluation of the NIH Senator Paul D. Wellstone Muscular Dystrophy Research Centers Program

Thu, 2018-06-21 09:32
Notice NOT-AR-18-021 from the NIH Guide for Grants and Contracts

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Wed, 2018-06-20 12:55
Funding Opportunity PA-18-837 from the NIH Guide for Grants and Contracts. The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) hereby notify Small Business Concerns (SBCs) holding Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants that funds are available for administrative supplements to improve the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from groups that have been shown to be nationally underrepresented in health-related research or in the SBIR program. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project. This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary study to a clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.

Notice of U.S. Department of Agriculture (USDA) Participation in PAR-17-482 Comparative Genomics Research Program (R01)

Wed, 2018-06-20 11:23
Notice NOT-HG-18-007 from the NIH Guide for Grants and Contracts

Notice Regarding New Applications for PAR-15-303: "Occupational Safety and Health Education and Research Centers (42)"

Wed, 2018-06-20 10:35
Notice NOT-OH-18-008 from the NIH Guide for Grants and Contracts

Notice of Clarification of NIA intent to fund awards for RFA-HL-18-023 "Stimulating Access to Research in Residency (StARR) (R38)"

Tue, 2018-06-19 12:36
Notice NOT-AG-18-022 from the NIH Guide for Grants and Contracts

Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)

Tue, 2018-06-19 12:29
Funding Opportunity RFA-AI-18-026 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the development and validation of modeling and simulation methods and related tools to examine HIV transmission dynamics, make epidemic projections, and estimate the impact of HIV treatment and prevention. Investigators are expected to share these resources with other researchers. Funding for the final fourth year is dependent upon achieving applicant-proposed and pre-award negotiated Go/No-Go criteria.

Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trials Optional)

Tue, 2018-06-19 11:46
Funding Opportunity PAR-18-835 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages grant applications for the conduct of innovative, collaborative research projects between U.S. and low- and middle-income country (LMIC) scientists, on brain and other nervous system function and disorders throughout life, relevant to LMICs (including neurological, mental, behavioral, alcohol and substance use disorders and spanning the full range of science from basic to implementation research). Scientists in upper middle-income LMICs (UMICs) are also eligible to partner directly with scientists at other LMIC institutions with or without out a US partner. Income categories are defined by the World Bank at http://data.worldbank.org/about/country-classifications/country-and-lending-groups.

Pages